All articles
Can Ozempic® Cause Hair Loss?
Reading time:
5 min
Weight loss

Get expert guidance and a personalized care plan designed around you.
Do other GLP-1 Medications Cause Hair Loss?
Ozempic® is part of the GLP-1 receptor agonists’ class of drugs, which includes several medications used for diabetes and weight management. Similar to Ozempic®, other GLP-1 medications could potentially lead to hair loss due stress on the body caused by significant weight loss in a short amount of time.The occurrence of hair loss is likely due to the lifestyle changes associated with their use, rather than the drugs themselves. Research is ongoing, and individual experiences may vary.
For more details on link between hair loss and other medications, explore our detailed breakdowns here:
Learn more here about the uses and outcomes of other medications offered within our program.
Key Takeaways For Managing Ozempic® Side Effects
In conclusion, while Ozempic® and other GLP-1 medications have transformed the management of diabetes and weight loss for many, concerns about side effects such as hair loss are valid. The connection between Ozempic® and hair loss isn’t fully understood, and further research is needed. However, recognizing the potential triggers and implementing preventive measures can help manage and mitigate this concerning side effect. Always consult a healthcare provider before changing your medication or lifestyle to address hair loss.
Take control of your weight management journey with personalized care from Mochi Health. Join our community today for expert guidance tailored to your unique health needs. Find out if you're eligible for our comprehensive weight care program and start your path to a healthier, happier you.
References:
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England journal of medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
Moll, Hannah, et al. “A Living Benefit-Harm Modelling Study of GLP-1 Receptor Agonists for Weight Reduction in Non-Diabetic Obese and Overweight Individuals.” SSRN, 1 Feb. 2024, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4709105
Hughes EC, Saleh D. Telogen Effluvium. [Updated 2023 May 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK430848/#
Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen Effluvium: A Review of the Literature. Cureus. 2020 May 27;12(5):e8320. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320655/
Almohanna, H. M., Ahmed, A. A., Tsatalis, J. P., & Tosti, A. (2019). The Role of Vitamins and Minerals in Hair Loss: A Review. Dermatology and therapy, 9(1), 51–70. https://doi.org/10.1007/s13555-018-0278-6
This post was written by our team of health writers for informational purposes only and does not constitute medical advice. Always consult your doctor or healthcare provider for personalized guidance regarding your health. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® and their delivery device are registered trademarks. Mochi Health is a telehealth clinic that offers prescriptions for these products by medical necessity only as determined by a licensed health provider.
Share this post
Weight loss
More articles















